Theeuwes, W. F., Pansters, N. A. M., Gosker, H. R., Schols, A. M. W. J., Verhees, K. J. P., de Theije, C. C., van Gorp, R. H. P., Kelders, M. C. J. M., Ronda, O., Haegens, A., Remels, A. H., & Langen, R. C. J. (2020). Recovery of muscle mass and muscle oxidative phenotype following disuse does not require GSK-3 inactivation. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1866(6), Article 165740. https://doi.org/10.1016/j.bbadis.2020.165740
Remels, A. H. V., Derks, W. J. A., Cillero-Pastor, B., Verhees, K. J. P., Kelders, M. C., Heggermont, W., Carai, P., Summer, G., Ellis, S. R., de Theije, C. C., Heeren, R. M. A., Heymans, S., Papageorgiou, A. P., & van Bilsen, M. (2018). NF-kappa B-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1864(8), 2579-2589. https://doi.org/10.1016/j.bbadis.2018.04.022
Theeuwes, W. F., Gosker, H. R., Langen, R. C. J., Verhees, K. J. P., Pansters, N. A. M., Schols, A. M. W. J., & Remels, A. H. V. (2017). Inactivation of glycogen synthase kinase-3 beta (GSK-3 beta) enhances skeletal muscle oxidative metabolism. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1863(12), 3075-3086. https://doi.org/10.1016/j.bbadis.2017.09.018
Pansters, N. A. M., Schols, A. M., Verhees, K. J., de Theije, C. C., Snepvangers, F., Kelders, M. C. J. M., Ubags, N. D. J., Haegens, A., & Langen, R. C. (2015). Muscle-specific GSK-3beta ablation accelerates regeneration of disuse-atrophied skeletal muscle. Biochimica et Biophysica Acta. Mucoproteins and Mucopolysaccharides, 1852(3), 490-506. https://doi.org/10.1016/j.bbadis.2014.12.006
Remels, A., Gosker, H., Koen Verhees, K. J. P., Langen, R., & Schols, A. (2015). TNF-alpha-Induced NF-kappa B Activation Stimulates Skeletal Muscle Glycolytic Metabolism Through Activation of HIF-1 alpha. Endocrinology, 156(5), 1770-1781. https://doi.org/10.1210/en.2014-1591
Verhees, K. J. P., Pansters, N. A. M., Schols, A. M. W. J., & Langen, R. C. J. (2013). Regulation of skeletal muscle plasticity by glycogen synthase kinase-3β: a potential target for the treatment of muscle wasting. Current Pharmaceutical Design, 19(18), 3276-3298. https://doi.org/10.2174/1381612811319180011
Koen Verhees, K. J. P. (2013). No time to waste : a glycogen synthase kinase‐3β ‐ glucocorticoid receptor signaling axis illuminated. [Doctoral Thesis, Maastricht University]. Maastricht University. https://doi.org/10.26481/dis.20130619kv
Verhees, K. J., Pansters, N. A. M., Baarsma, H. A., Remels, A. H., Haegens, A., de Theije, G. C., Schols, A. M., Gosens, R., & Langen, R. C. (2013). Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy. Respiratory Research, 14, 117. https://doi.org/10.1186/1465-9921-14-117
Koen Verhees, K. J. P., Schols, A. M. W. J., Kelders, M. C., Op den Kamp, C. M. H., van der Velden, J., & Langen, R. C. J. (2011). Glycogen synthase kinase-3ß is required for the induction of skeletal muscle atrophy.American Journal of Physiology-Cell Physiology, 301(5), C995-C1007. https://doi.org/10.1152/ajpcell.00520.2010
